Senator Rand Paul Introduces Resolution to Repeal FDA’s LDT Final Rule
Senator Rand Paul announced a resolution to repeal the FDA’s LDT Final Rule, arguing it oversteps authority and threatens medical innovation.
Read MorePosted by Andy Lundin | May 21, 2024 | Compliance |
Senator Rand Paul announced a resolution to repeal the FDA’s LDT Final Rule, arguing it oversteps authority and threatens medical innovation.
Read MorePosted by Chris Wolski | May 15, 2024 | Lab Management |
Green initiatives can go a long ways to cut waste and positively impact the bottom line for clinical laboratories.
Read MorePosted by Andy Lundin | May 14, 2024 | Covid 19 |
The FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read MorePosted by Chris Wolski | May 9, 2024 | Diagnostic Technologies |
The LDT final rule has sent shock waves through the clinical diagnostics industry. Should you be worried, and what can you do about it?
Read MorePosted by Andy Lundin | May 9, 2024 | Digital Pathology |
Indica Labs received FDA clearance for HALO AP Dx, an enterprise digital pathology platform for primary diagnosis.
Read More